G. Burke

发表

Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplant Recipients Given Tacrolimus and Daclizumab/Thymoglobulin: One Year Follow-Up

J. Gaynor, G. Ciancio, G. Burke, 2008, Transplantation.

Clinical Operational Tolerance After Renal Transplantation: Current Status and Future Challenges

S. Soker, R. Stratta, K. Wood, 2010, Annals of surgery.

Expanded liver donor age over 60 years for hepatic transplantation.

J. D. Waters, A. Tsaroucha, A. Tzakis, 1997, Transplantation proceedings.

Predisposing Factors of Diminished Survival in Simultaneous Liver/Kidney Transplantation

T. Hibi, G. Selvaggi, S. Nishida, 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Current treatment practice in immunosuppression

G. Ciancio, G. Burke, Joshua Miller, 2000, Expert opinion on pharmacotherapy.

Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement.

A. Tzakis, G. Ciancio, G. Burke, 1999, Transplantation.

A. Tzakis, G. Ciancio, G. Burke, 1998, Transplantation proceedings.

Delville recurrence after kidney transplantation A circulating antibody panel for pretransplant prediction of FSGS

M. Sarwal, G. Canaud, A. Fornoni, 2014 .

A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation

M. Sarwal, G. Canaud, A. Fornoni, 2014, Science Translational Medicine.

Quantitative in Situ Analysis of FoxP3+ T Regulatory Cells on Transplant Tissue Using Laser Scanning Cytometry

A. Miki, C. Ricordi, A. Tzakis, 2012, Cell transplantation.

Recurrence of type 1 diabetes following simultaneous pancreas-kidney transplantation

J. Figueiró, G. Ciancio, G. Burke, 2020 .

Type 1 Diabetes Recurrence After Simultaneous Pancreas-Kidney Transplantation

J. Figueiró, G. Ciancio, G. Burke, 2018, Current Transplantation Reports.

Favorable Outcomes With Machine Perfusion and Longer Pump Times in Kidney Transplantation: A Single-Center, Observational Study

W. O’Neill, J. Gaynor, G. Ciancio, 2010, Transplantation.

Diabetic muscle infarction after simultaneous pancreas‐kidney transplant

J. Figueiró, G. Ciancio, G. Burke, 2002, Clinical transplantation.

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. Ii. Survival, function, and protocol compliance at 1 year

J. Gaynor, G. Ciancio, G. Burke, 2004, Transplantation.

A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year

J. Gaynor, G. Ciancio, G. Burke, 2004, Transplantation.

Nephrin Contributes to Insulin Secretion and Affects Mammalian Target of Rapamycin Signaling Independently of Insulin Receptor.

D. Maiguel, T. B. Huber, P. Berggren, 2016, Journal of the American Society of Nephrology : JASN.

Successful surgical salvage of pancreas allografts after complete venous thrombosis.

L. Fernandez, G. Ciancio, G. Burke, 2000, Transplantation.

Partial venous thrombosis of the pancreatic allografts after simultaneous pancreas–kidney transplantation

G. Ciancio, G. Burke, Joshua Miller, 2000, Clinical transplantation.

Pretransplant Levels of C-Reactive Protein, Soluble TNF Receptor-1, and CD38+HLADR+ CD8 T Cells Predict Risk of Allograft Rejection in HIV+ Kidney Transplant Recipients

G. Burke, J. Camargo, M. Alcaide, 2019, Kidney international reports.

Roux‐en‐Y gastric bypass is an effective bridge to kidney transplantation: Results from a single center

J. Gaynor, G. Ciancio, G. Burke, 2018, Clinical transplantation.

Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature

A. Tzakis, G. Burke, G. Procop, 2009, Transplant infectious disease : an official journal of the Transplantation Society.

Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis

M. Rastaldi, C. Ricordi, A. Fornoni, 2011, Science Translational Medicine.

Ten-Year Follow-up of a Reused Kidney Graft for Transplant Using Sirolimus for Maintenance Immunosuppression.

P. Ruiz, G. Ciancio, G. Burke, 2015, Transplantation proceedings.

New Insight on Human Type 1 Diabetes Biology: nPOD and nPOD-Transplantation

M. Atkinson, H. Reijonen, G. Burke, 2014, Current Diabetes Reports.

Rhabdomyolysis with acute kidney injury in deceased donors is not a contraindication for kidney donation

G. Ciancio, G. Burke, J. Sageshima, 2012, International Urology and Nephrology.

A novel approach to detect donor/recipent immune responses between HLA-identical pairs.

G. Ciancio, G. Burke, A. Rosen, 2005, Human immunology.

Islet and Pancreas Transplantation

C. Ricordi, R. Alejandro, D. Mineo, 2009 .

The impact of hepatitis C virus infection on renal allograft recipients.

G. Burke, D. Roth, Joshua Miller, 1994, Kidney international.

Type 2 Diabetes: Is Pancreas Transplantation an Option?

G. Ciancio, G. Burke, 2014, Current Diabetes Reports.

Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas–Kidney Transplants

S. Messinger, H. Reijonen, G. Ciancio, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity

S. Messinger, H. Reijonen, G. Ciancio, 2015, Current Diabetes Reports.

Antibody‐mediated rejection implies a poor prognosis in kidney transplantation: Results from a single center

J. Gaynor, G. Ciancio, G. Burke, 2018, Clinical transplantation.

Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis

V. Nair, M. Kretzler, A. Fornoni, 2019, PloS one.

Abatacept in B7-1-positive proteinuric kidney disease.

M. Arnaout, D. Maiguel, P. Fiorina, 2013, The New England journal of medicine.

Bone Marrow-Induced Tolerance in the Era of Pancreas and Islets Transplantation

G. Ciancio, G. Burke, S. Delis, 2006, Pancreas.

Donor bone marrow transplantation: chimerism and tolerance.

G. Ciancio, G. Burke, Joshua Miller, 2004, Transplant immunology.

Immunology in Pancreas Transplantation

R. Gruessner, G. Ciancio, G. Burke, 2004 .

A Randomized Pilot Study of Donor Stem Cell Infusion in Living-Related Kidney Transplant Recipients Receiving Alemtuzumab

C. Ricordi, J. Gaynor, G. Ciancio, 2013, Transplantation.

FoxP3 mRNA Transcripts and Regulatory Cells in Renal Transplant Recipients 10 Years After Donor Marrow Infusion

B. Blomberg, C. Ricordi, J. Gaynor, 2007, Transplantation.

Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.

B. Blomberg, C. Ricordi, A. Tzakis, 2003, Transplant immunology.

Human donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cells.

C. Ricordi, A. Tzakis, G. Ciancio, 2003, Human immunology.

Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.

C. Ricordi, N. Kenyon, A. Tzakis, 2002, Transplantation.

Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation.

C. Ricordi, A. Tzakis, G. Ciancio, 2002, Transplantation.

SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1

C. Ricordi, A. Tzakis, G. Ciancio, 2001, Transplantation.

Perioperative donor bone marrow infusion in cadaver kidney transplant recipients.

B. Blomberg, C. Ricordi, A. Tzakis, 2001, Transplantation proceedings.

Donor bone marrow infusions are tolerogenic in human renal transplantation.

C. Ricordi, N. Kenyon, A. Tzakis, 2001, Transplantation proceedings.

Donor bone marrow cells used for the induction of allograft acceptance in clinical transplantation as regulators of autologous immune responses.

C. Ricordi, A. Tzakis, G. Burke, 2001, Transplantation proceedings.

Cells of donor phenotype present in renal transplant recipients infused with donor marrow: potent regulators of antidonor immune responses of the recipient.

C. Ricordi, A. Tzakis, G. Burke, 2001, Transplantation Proceedings.

INVOLVEMENT OF MULTIPLE SUBPOPULATIONS OF HUMAN BONE MARROW CELLS IN THE REGULATION OF ALLOGENEIC CELLULAR IMMUNE RESPONSES1

C. Ricordi, A. Tzakis, G. Burke, 2000, Transplantation.

DONOR BONE MARROW-DERIVED CHIMERIC CELLS PRESENT IN RENAL TRANSPLANT RECIPIENTS INFUSED WITH DONOR MARROW. I. POTENT REGULATORS OF RECIPIENT ANTIDONOR IMMUNE RESPONSES1

C. Ricordi, A. Tzakis, G. Ciancio, 2000, Transplantation.

Donor bone marrow infusion in renal transplantation.

C. Ricordi, A. Tzakis, G. Ciancio, 1998, Transplantation Proceedings.

Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.

C. Ricordi, N. Kenyon, A. Tzakis, 1998, Transplantation.

The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.

C. Ricordi, A. Tzakis, G. Ciancio, 1997, The Journal of clinical investigation.

Assessment of the effects of cadaveric donor bone marrow on chimerism in kidney transplant recipients by the polymerase chain reaction-flow technique.

C. Ricordi, A. Tzakis, G. Ciancio, 1997, Transplantation proceedings.

PCR-flow analysis used to detect the levels of chimerism in peripheral blood of bone-marrow infused organ allograft recipients at the time of rejection episodes.

C. Ricordi, A. Tzakis, G. Ciancio, 1997, Transplantation proceedings.

An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry.

C. Ricordi, A. Tzakis, G. Ciancio, 1996, Transplantation.

Tacrolimus and Mycophenolate Mofetil Regimens in Transplantation

G. Ciancio, G. Burke, D. Roth, 1999, BioDrugs.

Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients1

G. Ciancio, G. Burke, D. Roth, 2002, Transplantation.

Transplant-associated autoimmune mechanisms in human hepatitis C virus infection

A. Tzakis, G. Burke, D. Roth, 2005, Journal of Clinical Immunology.

Transmission of hepatitis C virus by kidney transplantation: impact of perfusion techniques and course of viremia post transplant

G. Burke, D. Roth, Joshua Miller, 2004, Pediatric Nephrology.

Differential effects of IFN-gamma on kidney cell expression of MHC class II molecules, kidney cell associated molecules and their stimulatory capacity in mixed lymphocyte kidney cell culture.

P. Lu, G. Burke, D. Roth, 1993, Transplant immunology.

Cross-species reactivity of the anti-idiotype anti-OKT3 cascade between mice and humans.

G. Burke, V. Esquenazi, J. Nery, 1992, Human immunology.

Induction of Auto-reactive Regulatory T Cells by Stimulation with Immature Autologous Dendritic Cells

B. Blomberg, C. Ricordi, A. Tzakis, 2007, Immunological investigations.

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease

R. Inagi, A. Mendez, T. Yoo, 2019, Nature Communications.

Characterization of anti-canine cytokine monoclonal antibodies specific for IFN-γ: Effect of anti-IFN-γ on renal transplant rejection

G. Burke, D. Roth, Joshua Miller, 1994 .

Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression.

J. Skyler, C. Ricordi, R. Alejandro, 1998, Transplantation proceedings.

Anti-Proinflammatory Effects of Sirolimus on Human Islet Preparations

A. Miki, C. Ricordi, L. Inverardi, 2008, Transplantation.

Recurrence of autoimmunity in pancreas transplant patients: research update.

H. Reijonen, G. Burke, A. Pugliese, 2011, Diabetes management.

Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.

C. Forsblom, P. Groop, M. Kretzler, 2015, Journal of the American Society of Nephrology : JASN.

A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1

J. Gaynor, A. Tzakis, G. Ciancio, 2005, Transplantation.

Functional and phenotypic properties of peripheral T cells anergized by autologous CD3(+) depleted bone marrow cells.

B. Blomberg, C. Ricordi, A. Tzakis, 2002, Human immunology.

Induction Therapy in Renal Transplantation

G. Ciancio, G. Burke, Joshua Miller, 2012, Drugs.

A Randomized Long-Term Trial of Tacrolimus/Sirolimus versus Tacrolimums/Mycophenolate versus Cyclosporine/Sirolimus in Renal Transplantation: Three-Year Analysis

J. Gaynor, G. Ciancio, G. Burke, 2006, Transplantation.

Allosensitization of Islet Allograft Recipients

C. Ricordi, R. Alejandro, T. Froud, 2007, Transplantation.

ADVANCES IN PANCREAS TRANSPLANTATION

H. Sollinger, G. Ciancio, G. Burke, 2004, Transplantation.

Recurrence of Autoimmunity Following Pancreas Transplantation

H. Reijonen, G. Ciancio, G. Burke, 2011, Current diabetes reports.

A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.

R. Stratta, P. Stock, E. Benedetti, 1996, Transplantation.

Minimization and withdrawal of steroids in pancreas and islet transplantation

C. Ricordi, D. Mineo, G. Burke, 2009, Transplant international : official journal of the European Society for Organ Transplantation.

International Survey of Clinical Monitoring Practices in Pancreas and Islet Transplantation

M. Rickels, R. Stratta, E. D. de Koning, 2022, Transplantation.

Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation.

G. Nepom, G. Burke, A. Pugliese, 2008, Clinical immunology.

Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation.

J. Gaynor, G. Ciancio, G. Burke, 2011, Transplant immunology.

Early development of acute myelogenous leukemia following kidney transplantation: possible role of multiple serum cytokines.

G. Burke, D. Roth, J. Nery, 1995, Leukemia & lymphoma.

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

E. Salido, M. Sarwal, M. Rastaldi, 2011, Nature Medicine.

Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era.

G. Ciancio, G. Burke, D. Roth, 1997, Clinical transplantation.

Results of renal transplantation in Miami analyzed by race.

G. Burke, D. Roth, V. Esquenazi, 1989, Transplantation proceedings.

Predictors of reduced tacrolimus dose and trough level through 36 months post‐transplant among 578 adult primary kidney transplant recipients

J. Gaynor, G. Ciancio, G. Burke, 2014 .

Machine perfusion following static cold storage preservation in kidney transplantation: donor‐matched pair analysis of the prognostic impact of longer pump time

J. Gaynor, G. Ciancio, G. Burke, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C

T. Hibi, S. Nishida, D. Levi, 2014, Transplant international : official journal of the European Society for Organ Transplantation.

More than 5-year islet allograft function in insulin-dependent diabetes mellitus.

C. Ricordi, R. Alejandro, D. Mintz, 1997, Transplantation proceedings.

The presence of hepatitis B core antibody does not preclude kidney donation: lack of viral DNA in the serum and biopsies of core antibody-positive donors and clinical follow-up.

A. Tzakis, G. Burke, V. Esquenazi, 1997, Transplantation.

De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients.

P. Ruiz, G. Burke, D. Roth, 1995, Transplantation.

Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation.

G. Burke, D. Roth, V. Esquenazi, 1995, Transplantation proceedings.

DEPLETION OF HEPATITIS C VIRUS FROM PROCURED KIDNEYS USING PULSATILE PERFUSION PRESERVATION1,2

G. Burke, D. Roth, Joshua Miller, 1994, Transplantation.

Transmission of hepatitis C virus with solid organ transplantation: incidence and clinical significance.

G. Burke, D. Roth, V. Esquenazi, 1993, Transplantation proceedings.

Detection of Hepatitis C Virus Infection among Cadaver Organ Donors: Evidence for Low Transmission of Disease

E. Schiff, G. Burke, D. Roth, 1992, Annals of Internal Medicine.

ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.

V. Nair, M. Kretzler, R. Nelson, 2019, The Journal of clinical investigation.

Transplantation of kidneys from hepatitis C‐positive donors into hepatitis C virus‐infected recipients followed by early initiation of direct acting antiviral therapy: a single‐center retrospective study

G. Ciancio, G. Burke, D. Roth, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes

N. Morgan, S. Richardson, F. Arfuso, 2021, Diabetologia.

Effect of cyclosporine A on serum tumor necrosis factor alpha in new-onset type I (insulin-dependent) diabetes mellitus.

J. Skyler, G. Burke, A. Rabinovitch, 1994, Journal of diabetes and its complications.

Longitudinal induced IL-2 mRNA monitoring in renal transplant patients immunosuppressed with cyclosporine and in unmodified canine renal transplant rejection.

P. Ruiz, G. Burke, V. Esquenazi, 1996, Human immunology.

Never events and hospital-acquired conditions after kidney transplant.

G. Ciancio, G. Burke, Z. Moghadamyeghaneh, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Randomized Trial of Three Induction Antibodies in Kidney Transplantation: Long-Term Results

J. Gaynor, G. Ciancio, G. Burke, 2014, Transplantation.

Campath-1H Induction Therapy in African American and Hispanic First Renal Transplant Recipients: 3-Year Actuarial Follow-Up

J. Gaynor, G. Ciancio, G. Burke, 2008, Transplantation.

The Use of Campath-1H as Induction Therapy in Renal Transplantation: Preliminary Results

J. Gaynor, A. Tzakis, G. Ciancio, 2004, Transplantation.

Early graft loss secondary to massive hemorrhagic necrosis following orthotopic liver transplantation. Evidence for cytokine-mediated univisceral Shwartzman reaction.

E. Schiff, P. Ruiz, A. Tzakis, 1996, Transplantation.

Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.

C. Ricordi, A. Tzakis, G. Ciancio, 2004, Human immunology.

Association of interleukin-10 with rejection-sparing effect in septic kidney transplant recipients.

G. Ciancio, G. Burke, D. Roth, 1996, Transplantation.

Long-term function of islet allograft in type I diabetes mellitus.

C. Ricordi, R. Alejandro, D. Mintz, 1995, Transplantation proceedings.

Efficacy of Alemtuzumab in Organ Transplantation

G. Ciancio, G. Burke, Joshua Miller, 2012, BioDrugs.

PROSPECTIVE, RANDOMIZED TRIAL OF THE EFFECT OF ANTIBODY INDUCTION IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION: THREE-YEAR RESULTS1

M. Stegall, A. Henning, A. Gaber, 2004, Transplantation.

The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas–kidney recipients with previous transplants

G. Ciancio, G. Burke, Joshua Miller, 2001, Clinical transplantation.

Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas-kidney transplantation

G. Ciancio, G. Burke, A. L. Lo Monte, 2000 .

Use of tacrolimus and mycophenolate mofetil as induction and maintenance in simultaneous pancreas‐kidney transplantation

G. Ciancio, G. Burke, J. Miller, 2000, Transplant international : official journal of the European Society for Organ Transplantation.

Vascular complications following bladder drained, simultaneous pancreas‐kidney transplantation: the University of Miami experience

G. Ciancio, G. Burke, J. Miller, 2000, Transplant International.

Molecular monitoring of the immunosuppressive effects of cyclosporine in renal transplant patients by using a quantitative polymerase chain reaction.

G. Burke, D. Roth, V. Esquenazi, 1993, Human immunology.

Podocyte Effacement Closely Links to suPAR Levels at Time of Posttransplantation Focal Segmental Glomerulosclerosis Occurrence and Improves With Therapy

H. Rabb, A. Fornoni, G. Burke, 2013, Transplantation.

Vascular complications following bladder drained, simultaneous pancreas-kidney transplantation: the University of Miami experience

G. Ciancio, G. Burke, A. L. Lo Monte, 2000 .

Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients.

G. Ciancio, G. Burke, P. Ruiz, 2016, Transplant immunology.

Campath-1H does not alter bone marrow cell regulatory function.

C. Ricordi, A. Tzakis, G. Ciancio, 2005, Human immunology.

Vertebral body procurement from multiorgan donors for bone marrow harvest.

J. D. Waters, C. Ricordi, A. Tzakis, 1997, Transplantation proceedings.

Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients.

G. Ciancio, G. Burke, D. Roth, 2002, Transplantation proceedings.

Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal

J. Figueiró, A. Fornoni, G. Ciancio, 2022, Pediatric Nephrology.

Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction.

C. Ricordi, R. Alejandro, A. Tzakis, 1998, Transplantation proceedings.

FK 506 in simultaneous pancreas/kidney transplantation: the University of Miami experience.

A. Tzakis, G. Ciancio, G. Burke, 1997, Transplantation Proceedings.

Conversion of whole pancreaticoduodenal transplants from bladder to enteric drainage for metabolic acidosis or dysuria.

D. Dunn, D. Sutherland, R. Gruessner, 1990, Transplantation proceedings.

Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantation

J. Gaynor, G. Ciancio, G. Burke, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Everolimus with low‐dose tacrolimus in simultaneous pancreas and kidney transplantation

T. Dohi, G. Ciancio, G. Burke, 2014, Clinical transplantation.

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation

G. Ciancio, G. Burke, J. Sageshima, 2009, Biologics : targets & therapy.

Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation

G. Ciancio, G. Burke, J. Sageshima, 2009 .

Liver transplantation for cirrhosis following jejuno-ileal bypass--regional cytokine differences associated with pathological changes in the transplant liver.

E. Schiff, G. Burke, Joshua Miller, 1992, Transplantation.

Regarding Maas's editorial letter on serum suPAR levels.

D. Gipson, G. Ghiggeri, F. Schaefer, 2012, Kidney International.

Podocyte foot process effacement in postreperfusion allograft biopsies.

A. Fornoni, G. Ciancio, G. Burke, 2014, Transplantation.

A Pivotal Circulating Antibody Panel for Pre-Transplant Prediction of FSGS Recurrence After Kidney Transplantation.: Abstract# 2202

M. Sarwal, G. Canaud, A. Fornoni, 2014 .

How to Deal With Kidney Retransplantation—Second, Third, Fourth, and Beyond

J. Figueiró, G. Ciancio, G. Burke, 2021, Transplantation.

Percutaneous sclerotherapy of lymphoceles related to renal transplantation.

B. Montalvo, J. Yrizarry, G. Burke, 1996, Journal of vascular and interventional radiology : JVIR.

Midline Rotation of the Right Renal Hilum During Hand-Assisted Laparoscopic Living Donor Nephrectomy

J. Gaynor, G. Ciancio, G. Burke, 2021, JSLS : Journal of the Society of Laparoendoscopic Surgeons.

Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplantation With Tacrolimus and Steroid Avoidance: Four-Year Analysis

J. Gaynor, G. Ciancio, G. Burke, 2011, Transplantation.

Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients

G. Ciancio, G. Burke, D. Roth, 1998 .

Birefringent crystals in a lung cavity.

P. Bejarano, G. Burke, L. Dowdy, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunosuppressive treatment options in renal transplantation.

G. Ciancio, G. Burke, A. Rosen, 2005, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

Lack of clinical association and effect of peripheral WBC counts on immune cell function test in kidney transplant recipients with T-cell depleting induction and steroid-sparing maintenance therapy.

T. Dohi, J. Gaynor, G. Ciancio, 2014, Transplant immunology.

The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression.

J. Skyler, C. Ricordi, R. Alejandro, 1995, Transplantation proceedings.

Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.

A. Tsaroucha, A. Tzakis, G. Ciancio, 1997, Transplant immunology.

Improved Metabolic Control and Quality of Life in Seven Patients With Type 1 Diabetes Following Islet After Kidney Transplantation

S. Messinger, C. Ricordi, R. Alejandro, 2008, Transplantation.

BK virus nephropathy after simultaneous pancreas–kidney transplantation

G. Ciancio, G. Burke, D. Roth, 2010, Clinical transplantation.

Effect of kidney transplantation on outcomes among patients with hepatitis C.

K. Reddy, J. Gaynor, G. Ciancio, 2011, Journal of the American Society of Nephrology : JASN.

A prospective study of hepatitis C virus infection in renal allograft recipients.

G. Ciancio, G. Burke, D. Roth, 1996, Transplantation.

The human bone marrow as an immunoregulatory organ.

C. Ricordi, A. Tzakis, G. Ciancio, 1999, Transplantation.

Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation, Despite Immunosuppression, Is Associated With Autoantibodies and Pathogenic Autoreactive CD4 T-Cells

H. Reijonen, Zhibin Chen, C. Ricordi, 2010, Diabetes.

Use of Kidneys with Small Renal Tumors for Transplantation

G. Ciancio, G. Burke, G. Guerra, 2015, Current Urology Reports.

Multivariable risk of developing new onset diabetes after transplant—results from a single‐center study of 481 adult, primary kidney transplant recipients

J. Gaynor, G. Ciancio, G. Burke, 2015, Clinical transplantation.

Cyclodextrin Protects Podocytes in Diabetic Kidney Disease

C. Forsblom, P. Groop, V. Nair, 2013, Diabetes.

Absorbable cyanoacrylate surgical sealant in kidney transplantation.

G. Ciancio, G. Burke, J. Sageshima, 2011, Transplantation proceedings.

Simultaneous pancreas–kidney transplantation in Jehovah's Witness patients

J. Figueiró, G. Ciancio, G. Burke, 2003, Clinical transplantation.

Retrieval of the pancreas allograft for whole‐organ transplantation

R. Stratta, J. Rogers, C. Kubal, 2014, Clinical transplantation.

Preparation of the pancreas allograft for transplantation

R. Stratta, G. Ciancio, G. Burke, 2011, Clinical transplantation.

Kidney Transplantation Combined With Other Organs

G. Ciancio, G. Burke, J. Sageshima, 2017 .

Current Status of Pancreas Transplantation

G. Ciancio, G. Burke, J. Sageshima, 2014 .

Successful treatment for graft‐versus‐host disease after pancreas transplantation

G. Ciancio, G. Burke, J. Sageshima, 2014, Clinical transplantation.

Activated cytokine pattern in hepatorenal syndrome: fall in levels after successful orthotopic liver transplantation.

E. Schiff, G. Burke, D. Roth, 1993, Transplantation proceedings.

New insights into renal lipid dysmetabolism in diabetic kidney disease

A. Fornoni, G. Burke, S. Merscher, 2021, World journal of diabetes.

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease

R. Inagi, A. Mendez, T. Yoo, 2019, Nature Communications.

Podocyte-Specific GLUT4-Deficient Mice Have Fewer and Larger Podocytes and Are Protected From Diabetic Nephropathy

D. Maiguel, B. Kahn, T. Yoo, 2014, Diabetes.

The use of daclizumab as induction therapy in combination with tacrolimus and mycophenolate mofetil in recipients with previous transplants

G. Ciancio, G. Burke, D. Roth, 2003, Clinical transplantation.

Mannose binding lectin (mbl2) haplotype frequencies in solid organ transplant patients and correlation with MBL protein levels--evaluation of complement-mediated effector pathway deficiency.

A. Tzakis, S. Pham, G. Ciancio, 2013, Transplant immunology.

Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.

M. Kretzler, A. Mendez, A. Fornoni, 2018, Kidney international.

Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury.

C. Forsblom, P. Groop, O. Kretz, 2016, The Journal of clinical investigation.

Polyomavirus PCR monitoring in renal transplant recipients: detection in blood is associated with higher creatinine values.

A. Tzakis, G. Burke, D. Roth, 2001, Transplantation proceedings.

Genitourinary tuberculosis after renal transplantation: report of 3 cases and review.

C. Mies, G. Ciancio, G. Burke, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Case Report: Uroenteric Fistula in a Pediatric-en-bloc Kidney Transplant Manifests as Deceptive Watery Diarrhea and Normal Anion Gap Acidosis

G. Burke, J. Chandar, C. Abitbol, 2021, Frontiers in Pediatrics.

Randomized trial of rATg/Daclizumab vs. rATg/Alemtuzumab as dual induction therapy in renal transplantation: Results at 8years of follow-up.

J. Gaynor, G. Ciancio, G. Burke, 2017, Transplant immunology.

Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre‐ and post‐direct‐acting antiviral therapy eras: 10‐Year single center experience

J. Figueiró, G. Ciancio, G. Burke, 2019, Clinical transplantation.

A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow‐up

J. Gaynor, G. Ciancio, G. Burke, 2007, Clinical transplantation.

The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings

Clive Wasserfall, George W Burke, M. Atkinson, 2013, Pediatric diabetes.

Impact of antiretroviral therapy on clinical outcomes in HIV + kidney transplant recipients: Review of 58 cases

J. Figueiró, G. Ciancio, G. Burke, 2016, F1000Research.

Ex vivo repair and renal autotransplantation after penetrating trauma: is there an upper limit of ischemic/traumatic injury beyond which a kidney is unsalvageable?

J. Figueiró, J. Augenstein, G. Sfakianakis, 2003, The Journal of trauma.

Urodynamic findings following bladder-drained simultaneous pancreas-kidney transplantation.

G. Ciancio, G. Burke, C. Lynne, 1997, Transplantation proceedings.

Kidney recipient CMV incidence in the gancyclovir era: monitoring viral DNA by a CMV-PCR assay.

G. Ciancio, G. Burke, V. Esquenazi, 1999, Transplantation proceedings.

Rejection in HLA-identical living related donor kidney transplants: lack of predictive immunologic parameters.

G. Burke, D. Roth, V. Esquenazi, 1994, Transplantation.

Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants.

T. Kato, A. Tzakis, G. Ciancio, 2001, Transplantation proceedings.

Donor considerations in pediatric kidney transplantation

G. Ciancio, G. Burke, J. Chandar, 2020, Pediatric Nephrology.

Augmentation of mycophenolate mofetil pharmacokinetics in renal transplant patients receiving Prograf and CellCept in combination therapy.

A. Tsaroucha, A. Tzakis, G. Burke, 1997, Transplantation Proceedings.

Renal transplantation in a new immunosuppressive era.

G. Ciancio, G. Burke, D. Roth, 1995, Transplantation proceedings.

Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506.

G. Ciancio, G. Burke, D. Roth, 1997, Transplantation.

Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients.

G. Ciancio, G. Burke, A. Rosen, 2002, Transplantation proceedings.

The Use of Daclizumab, Tacrolimus and Mycophenolate Mofetil in African‐American and Hispanic First Renal Transplant Recipients

G. Ciancio, G. Burke, D. Roth, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation.

P. Ruiz, G. Ciancio, G. Burke, 1998, Transplantation proceedings.

Factors affecting the ten-year outcome of human renal allografts. The effect of viral infections.

G. Burke, D. Roth, V. Esquenazi, 1991, Transplantation.

Surgical Complications of Kidney–Pancreas Transplantation

P. Byers, G. Ciancio, G. Burke, 2006 .

Vascular Complications of Pancreas Transplantation

G. Ciancio, G. Burke, Joshua Miller, 2004, Pancreas.

Donor bone marrow infusion in simultaneous pancreas/kidney transplant recipients: a preliminary study.

C. Ricordi, R. Alejandro, G. Selvaggi, 1995, Transplantation proceedings.

Clinical management of the pediatric renal-allograft recipient.

G. Burke, G. Zilleruelo, J. Strauss, 1991, Child nephrology and urology.

Donor bone marrow, chimerism, histocompatibility and renal allograft rejection.

A. Tzakis, G. Ciancio, G. Burke, 1999, Transplantation proceedings.

Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients1

C. Ricordi, N. Kenyon, A. Tzakis, 2002 .

Renal Transplantation in a Patient With Unsuspected Inferior Vena Cava Obliteration

G. Ciancio, G. Burke, Linda J. Chen, 2016, Transplantation.

Case series: Transplantation of kidneys from donors with renal artery aneurysm.

G. Ciancio, G. Burke, M. Osman, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Hypercoagulable state associated with kidney–pancreas transplantation. Thromboelastogram‐directed anti‐coagulation and implications for future therapy

J. Figueiró, G. Ciancio, G. Burke, 2004, Clinical transplantation.

Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience

G. Ciancio, G. Burke, Joshua Miller, 2005, Pediatric Nephrology.

Rapidly progressive focal segmental glomerulosclerosis occurring in a living related kidney transplant donor: case report and review of 21 cases of kidney transplants for primary FSGS.

P. Ruiz, G. Burke, D. Roth, 1993, Transplantation proceedings.

Susceptibility‐directed anticoagulation after pancreas transplantation: A single‐center retrospective study

J. Figueiró, N. Namias, G. Ciancio, 2019, Clinical transplantation.

Arterial reconstruction with donor iliac vessels during pancreas transplantation: an intraoperative approach to arterial injury or inadequate flow

G. Ciancio, G. Burke, Jang Il Moon, 2005, Clinical transplantation.

Steroid-resistant acute rejection following SPK: importance of maintaining therapeutic dosing in a triple-drug regimen.

G. Ciancio, G. Burke, A. Rosen, 2002, Transplantation proceedings.

Can acute rejection be prevented in SPK transplantation?

G. Ciancio, G. Burke, A. Rosen, 2002, Transplantation proceedings.

Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression.

G. Ciancio, G. Burke, D. Roth, 2001, Transplantation proceedings.

The use of the brachiocephalic trunk for arterial reconstruction of the whole pancreas allograft for transplantation.

G. Ciancio, G. Burke, L. Olson, 1995, Journal of the American College of Surgeons.

Podocyte Foot Process Effacement in Postreperfusion Allograft Biopsies Correlates With Early Recurrence of Proteinuria in Focal Segmental Glomerulosclerosis

A. Fornoni, G. Ciancio, G. Burke, 2012, Transplantation.

Randomized Trial of Dual Antibody Induction Therapy With Steroid Avoidance in Renal Transplantation

J. Gaynor, G. Ciancio, G. Burke, 2011, Transplantation.

The elusive podocyte crossmatch for recurrent focal segmental glomerulosclerosis.

A. Fornoni, G. Burke, 2019, Kidney international.

Aneurysmectomy with Partial Nephrectomy on a Living Donor Renal Allograft: A Case Report

G. Ciancio, G. Burke, J. Sageshima, 2013, Case reports in transplantation.

Open or laparoscopic nephrectomy and extracoroporeal repair of complicated renal artery aneurysms: techniques for renal salvage.

G. Ciancio, G. Burke, V. Bird, 2011, Archivos espanoles de urologia.

When is it safe to perform abdominal transplantation in patients with prior SARS‐CoV‐2 infection: A case series

J. Figueiró, G. Ciancio, G. Burke, 2021, Clinical Transplantation.

A nationwide analysis of re-operation after kidney transplant.

G. Ciancio, G. Burke, Z. Moghadamyeghaneh, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Dual kidney transplantation using midline extraperitoneal approach: description of a technique.

H. Haider, G. Ciancio, G. Burke, 2007, Transplantation Proceedings.

Destructive allograft fungal arteritis following simultaneous pancreas-kidney transplantation.

P. Ruiz, E. Ginzburg, G. Ciancio, 1996, Transplantation.

Partial Bladder Transplantation with En Bloc Kidney Transplant—The First Case Report of a ‘Bladder Patch Technique’ in a Human

T. Kato, G. Selvaggi, A. Tzakis, 2008, American Journal of Transplantation.

Pulsatile perfusion preservation of en bloc kidneys from small pediatric donors.

G. Ciancio, G. Burke, J. Sageshima, 2009, Transplantation.

Transplantation of en bloc pediatric kidneys with a partial bladder segment in an adult recipient

G. Ciancio, G. Burke, J. Sageshima, 2009, Transplant international : official journal of the European Society for Organ Transplantation.

Emergent renal revascularization of a simultaneous pancreas-kidney transplant recipient.

M. Gorin, G. Ciancio, G. Burke, 2012, Transplantation.

Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism.

J. Skyler, C. Ricordi, R. Alejandro, 1995, Transplantation Proceedings.

Retrospective Assessment of Islet Cell Autoantibodies in Pancreas Organ Donors

G. Ciancio, G. Burke, A. Pugliese, 2008, Diabetes Care.

Islet cell transplantation: should we use more than one pancreas? Con.

G. Ciancio, G. Burke, 2002, Transplantation Proceedings.

Simultaneous ureterocystoplasty and living related renal transplantation.

G. Burke, R. Gosálbez, C. O. Kim, 1996, Clinical Transplantation.

Randomized trial of immunosuppressive regimens in renal transplantation.

J. Gaynor, G. Ciancio, G. Burke, 2011, Journal of the American Society of Nephrology : JASN.

Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results

J. Gaynor, G. Ciancio, G. Burke, 2020, Clinical transplantation.

Show me the money—immunosuppression in kidney transplantation

G. Ciancio, G. Burke, 2004, The Lancet.

Living donor nephrectomy: University of Miami technique and current results.

G. Ciancio, G. Burke, J. Sageshima, 2010, Archivos espanoles de urologia.

THE ROLE OF ANTIBODY INDUCTION IN SIMULTANEOUS PANCREAS KIDNEY (SPK) TRANSPLANT PATIENTS RECEIVING TACROLIMUS + MYCOPHENOLATE MOFETIL (MMF) IMMUNOSUPPRESSION.: Abstract# 357

M. Stegall, R. Merion, G. Danovitch, 2000 .

Allograft pancreatic duct dilatation following bladder drained simultaneous pancreas-kidney transplantation: clinical significance.

B. Montalvo, G. Ciancio, G. Burke, 2000, JOP : Journal of the pancreas.

COMBINED PANCREAS AND EN-BLOC KIDNEY TRANSPLANTATION FROM VERY SMALL PEDIATRIC DONORS: 145

G. Ciancio, G. Burke, J. Sageshima, 2008 .

Kidney transplantation with two donor ureters in patient with previous ileogastric conduit

C. Dervenis, G. Ciancio, G. Burke, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Positional obstructive uropathy secondary to ureteroneocystostomy herniation in a renal transplant recipient.

G. Ciancio, G. Burke, J. Nery, 1995, The Journal of urology.

Recurrence of lupus nephritis in a renal allograft with histologic transformation of the lesion.

G. Burke, D. Roth, M. Milgrom, 1990, Transplantation.

Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation.

J. Gaynor, G. Ciancio, G. Burke, 2010, Transplantation proceedings.

Biomarkers in pancreas transplant

G. Ciancio, G. Burke, A. Pugliese, 2016, Current opinion in organ transplantation.

Long-term results of kidney transplantation at the University of Miami.

G. Burke, D. Roth, A. Rosen, 1989, Clinical transplants.

Orthotopic liver transplantation: nonoperative management of early, acute portal vein thrombosis.

J. Najarian, D. Hunter, G. Burke, 1988, Surgery.

New technique in using the gonadal vein in lengthening the right renal vein in living donor kidney transplant.

G. Ciancio, G. Burke, J. Sageshima, 2012, Transplantation.

Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.

A G Tzakis, K R Reddy, E. Schiff, 2001, Archives of surgery.

Parametric Cause-Specific Hazard Modeling with Nonproportional Covariate Effects: A Case Study Using Liver Transplant Data

J. Moon, J. Gaynor, G. Selvaggi, 2010 .

REFLUX PANCREATITIS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION TREATED BY α1 BLOCKER

G. Ciancio, G. Burke, D. Roth, 1995 .

Characterization of RFs in TLOS of NOD mice. We conducted an in-depth characterization of the RFs in TLOs of NOD mice using a broad repertoire of antibodies directed against specific BM and interstitial matrix (IM) components

N. Morgan, S. Richardson, F. Arfuso, 2021 .

Disparities Among Blacks, Hispanics, and Whites in Time From Starting Dialysis to Kidney Transplant Waitlisting

J. Gaynor, G. Ciancio, G. Burke, 2013, Transplantation.

Kidney Salvage with Renal Artery Reconstruction after Blunt Traumatic Injury

A. Marttos, N. Namias, G. Ciancio, 2020, Case reports in urology.

Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients.

G. Ciancio, G. Burke, D. Roth, 1999, Transplantation.

CELLULAR PHENOTYPES AFFECTED BY INDUCTION THERAPY WITH CAMPATH-1H VS THYMOGLOBULIN VS ZENAPAX IN KIDNEY ALLOGRAFT RECIPIENTS

C. Ricordi, A. Tzakis, G. Ciancio, 2004 .

Detection of antibody to hepatitis C virus in renal transplant recipients.

G. Burke, D. Roth, Joshua Miller, 1991, Transplantation.

Long-term outcomes of IL-2R antibody vs antithymocyte globulin for induction therapy in kidney transplantation

G. Ciancio, G. Burke, 2007, Nature Clinical Practice Nephrology.

Graft Failure Due to Noncompliance Among 628 Kidney Transplant Recipients With Long-term Follow-up: A Single-Center Observational Study

J. Gaynor, G. Ciancio, G. Burke, 2014, Transplantation.

POSTTRANSPLANT HYPERGLYCEMIA: Increased Incidence in Cyclosporine‐Treated Renal Allograft Recipients“

G. Burke, D. Roth, Joshua Miller, 1989, Transplantation.

Insulin protein and proliferation in ductal cells in the transplanted pancreas of patients with type 1 diabetes and recurrence of autoimmunity

G. Sisino, H. Reijonen, C. Ricordi, 2008, Diabetologia.

Tacrolimus

G. Ciancio, G. Burke, D. Roth, 1997, Reactions weekly.

Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism.

J. Skyler, C. Ricordi, R. Alejandro, 1997, Transplantation proceedings.

Evidence for microchimerism in peripheral blood, bone marrow, and skin following donor bone marrow/kidney-pancreas transplantation at 3 years.

C. Ricordi, R. Alejandro, A. Tzakis, 1998, Transplantation proceedings.

Higher percentage of donor CD 34+ expression in peripheral blood of simultaneous pancreas/kidney/donor bone marrow versus than kidney/islet cell/donor bone marrow recipients.

C. Ricordi, R. Alejandro, A. Tzakis, 1998, Transplantation proceedings.

The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60.

G. Ciancio, G. Burke, D. Roth, 1997, Clinical transplantation.

Graft Failure Due to Nonadherence among 150 Prospectively-Followed Kidney Transplant Recipients at 18 Years Post-transplant: Our Results and Review of the Literature

J. Gaynor, G. Ciancio, G. Burke, 2022, Journal of clinical medicine.

A novel micro-cell-mediated lympholytic assay for the evaluation of regulatory cells in human alloreactive CTL responses.

B. Blomberg, C. Ricordi, N. Kenyon, 2003, Journal of immunological methods.

Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays.

E. Wang, B. Blomberg, C. Ricordi, 2010, Human immunology.

Retransplantation in a patient with type 2 Jeune's syndrome.

G. Burke, D. Roth, D. Banerjee, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.

C. Ricordi, A. Tzakis, G. Ciancio, 1996, Transplantation proceedings.

Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.

A. Miller, A. Pinna, G. Ciancio, 2001, Transplantation proceedings.

Twelve years' experience with non-heart-beating cadaveric donors.

A. Tzakis, G. Ciancio, G. Burke, 1996, Journal of transplant coordination : official publication of the North American Transplant Coordinators Organization.

Folie à Deux in Husband and Wife

J. Dawson, G. Burke, 1958 .

The effects of tissue-associated and MHC class II antigen presentation on in vitro lymphoproliferative responses against canine liver and kidney cell subpopulations.

R. Leif, G. Burke, D. Roth, 1991, Transplantation.

Toward the definition of nominal tissue-associated kidney tubular cell-surface epitope(s) which cause autologous and allogeneic T cell immune reactivity.

G. Burke, D. Roth, V. Esquenazi, 1989, Transplantation Proceedings.

P. Stock, R. Gruessner, G. Burke, 1998, Clinical transplantation.

Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Anti-interleukin-2 Receptor Antibodies—basiliximab and Daclizumab—for the Prevention of Acute Rejection in Renal Transplantation

G. Ciancio, G. Burke, J. Sageshima, 2022 .

Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression.

G. Ciancio, G. Burke, D. Roth, 2003, Transplantation proceedings.

A brief course of cyclosporine A pretransplant reduces posttransplant cyclosporine A requirements in beagles and humans.